BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 26561395)

  • 1. What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?
    Pelosi G; Fabbri A; Cossa M; Sonzogni A; Valeri B; Righi L; Papotti M
    Semin Diagn Pathol; 2015 Nov; 32(6):469-79. PubMed ID: 26561395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
    Schnabel PA; Junker K
    Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine neoplasms of the lung: Concepts and terminology.
    Wick MR; Marchevsky AM
    Semin Diagn Pathol; 2015 Nov; 32(6):445-55. PubMed ID: 26500079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary neuroendocrine tumors and preneoplasic lesions].
    Rouquette Lassalle I
    Ann Pathol; 2016 Jan; 36(1):34-43. PubMed ID: 26776366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
    Langfort R; Rudziński P; Burakowska B
    Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic difficulties with the diagnosis of small cell carcinoma of the lung.
    Marchevsky AM; Wick MR
    Semin Diagn Pathol; 2015 Nov; 32(6):480-8. PubMed ID: 26597580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in neuroendocrine lung tumors.
    Travis WD
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii65-71. PubMed ID: 20943645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroendocrine tumors of the lungs. From small cell lung carcinoma to diffuse idiopathic pulmonary neuroendocrine cell hyperplasia].
    Schnabel PA; Junker K
    Pathologe; 2014 Nov; 35(6):557-64. PubMed ID: 25366372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied.
    Fabbri A; Cossa M; Sonzogni A; Papotti M; Righi L; Gatti G; Maisonneuve P; Valeri B; Pastorino U; Pelosi G
    Virchows Arch; 2017 Feb; 470(2):153-164. PubMed ID: 28054150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine.
    Travis WD
    Thorac Surg Clin; 2014 Aug; 24(3):257-66. PubMed ID: 25065926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of neuroendocrine lung tumor classification.
    Travis WD; Gal AA; Colby TV; Klimstra DS; Falk R; Koss MN
    Hum Pathol; 1998 Mar; 29(3):272-9. PubMed ID: 9496831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine neoplasms of the lung: a prognostic spectrum.
    Asamura H; Kameya T; Matsuno Y; Noguchi M; Tada H; Ishikawa Y; Yokose T; Jiang SX; Inoue T; Nakagawa K; Tajima K; Nagai K
    J Clin Oncol; 2006 Jan; 24(1):70-6. PubMed ID: 16382115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems with the diagnosis of metastatic neuroendocrine neoplasms. Which diagnostic criteria should we use to determine tumor origin and help guide therapy?
    Koo J; Dhall D
    Semin Diagn Pathol; 2015 Nov; 32(6):456-68. PubMed ID: 26573790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.
    Skov BG; Holm B; Erreboe A; Skov T; Mellemgaard A
    J Thorac Oncol; 2010 Apr; 5(4):453-9. PubMed ID: 20104194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine tumors of the lung: clinicopathological and molecular features.
    Iyoda A; Azuma Y; Sano A
    Surg Today; 2020 Dec; 50(12):1578-1584. PubMed ID: 32193632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses.
    Yeh YC; Chou TY
    J Surg Oncol; 2014 Mar; 109(3):280-6. PubMed ID: 24301337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interobserver variability for the WHO classification of pulmonary carcinoids.
    Swarts DR; van Suylen RJ; den Bakker MA; van Oosterhout MF; Thunnissen FB; Volante M; Dingemans AM; Scheltinga MR; Bootsma GP; Pouwels HM; van den Borne BE; Ramaekers FC; Speel EJ
    Am J Surg Pathol; 2014 Oct; 38(10):1429-36. PubMed ID: 25046341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of changes in adults with multifocal pulmonary neuroendocrine proliferations: what is the minimum set of pathologic criteria to diagnose DIPNECH?
    Marchevsky AM; Wirtschafter E; Walts AE
    Hum Pathol; 2015 Feb; 46(2):176-81. PubMed ID: 25532694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Grading of neuroendocrine tumors].
    Saeger W; Schnabel PA; Komminoth P
    Pathologe; 2016 Jul; 37(4):304-13. PubMed ID: 27379621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.